(Q38196879)

30 August 2017

1 reference

title

Systematic review on the rapidity of the onset of action of topical treatments in the therapy of mild-to-moderate acne vulgaris (English)

1 reference

30 August 2017

1 reference

A Jacobs

1

1 reference

30 August 2017

G Starke

series ordinal

2

1 reference

30 August 2017

S Rosumeck

series ordinal

3

1 reference

30 August 2017

A Nast

series ordinal

4

1 reference

30 August 2017

language of work or name

English

0 references

publication date

1 March 2014

1 reference

British Journal of Dermatology

30 August 2017

published in

1 reference

30 August 2017

volume

170

1 reference

30 August 2017

issue

3

1 reference

30 August 2017

page(s)

557-564

1 reference

Which factors influence quality of life in acne patients?

30 August 2017

cites work

1 reference

European evidence-based (S3) guidelines for the treatment of acne.

21 January 2018

1 reference

Guidance on the diagnosis and clinical management of acne

21 January 2018

1 reference

Which antipsoriatic drug has the fastest onset of action? Systematic review on the rapidity of the onset of action.

21 January 2018

1 reference

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

Comparing 2.5%, 5%, and 10% benzoyl peroxide on inflammatory acne vulgaris.

21 January 2018

1 reference

Comparative effectiveness of benzoyl peroxide and tretinoin in acne vulgaris

21 January 2018

1 reference

A double-blind evaluation of topical isotretinoin 0.05%, benzoyl peroxide gel 5% and placebo in patients with acne

21 January 2018

1 reference

Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.

21 January 2018

1 reference

Topical adapalene gel 0.1% vs. isotretinoin gel 0.05% in the treatment of acne vulgaris: a randomized open-label clinical trial

21 January 2018

1 reference

A comparative trial of two retinoids commonly used in the treatment of acne vulgaris

21 January 2018

1 reference

Comparison of adapalene 0.1% solution and tretinoin 0.025% gel in the topical treatment of acne vulgaris.

21 January 2018

1 reference

Topical isotretinoin vs. topical retinoic acid in the treatment of acne vulgaris.

21 January 2018

1 reference

Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with benzoyl peroxide, clindamycin and vehicle gel in the treatments of acne vulgaris

21 January 2018

1 reference

Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations

21 January 2018

1 reference

A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris

21 January 2018

1 reference

Prospective, open-label, comparative study of clindamycin 1%/benzoyl peroxide 5% gel with adapalene 0.1% gel in Asian acne patients: efficacy and tolerability

21 January 2018

1 reference

Eligibility creep: a cause for placebo group improvement in controlled trials of psoriasis treatments

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJD.12706

1 reference

30 August 2017

1 reference